Illumina (NASDAQ: ILMN) enjoyed a tremendous year in 2017, with its share price soaring more than 70%. The launch of the gene-sequencing pioneer's new NovaSeq system was a huge success. That success has continued into 2018, with Illumina recently touching yet another all-time high share price. But is Illumina stock one to buy, sell, or hold after its huge gains?
Comment on Illumina Just Hit an All-Time High: Buy, Sell, or Hold?
newsfeedback@fool.com (Keith Speights), The Motley Fool
Tue, 03/20/2018 - 3:31am
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more